留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

视神经脊髓炎谱系病认知障碍病理机制和相关因素研究进展

芮钱芸 曹树刚 周笑灵 王晓缘 薛群

芮钱芸, 曹树刚, 周笑灵, 王晓缘, 薛群. 视神经脊髓炎谱系病认知障碍病理机制和相关因素研究进展[J]. 中华全科医学, 2022, 20(7): 1199-1202. doi: 10.16766/j.cnki.issn.1674-4152.002557
引用本文: 芮钱芸, 曹树刚, 周笑灵, 王晓缘, 薛群. 视神经脊髓炎谱系病认知障碍病理机制和相关因素研究进展[J]. 中华全科医学, 2022, 20(7): 1199-1202. doi: 10.16766/j.cnki.issn.1674-4152.002557
RUI Qian-yun, CAO Shu-gang, ZHOU Xiao-ling, WANG Xiao-yuan, XUE Qun. Advances of the pathological mechanism and related factors of cognitive impairment in neuromyelitis optica spectrum disorders[J]. Chinese Journal of General Practice, 2022, 20(7): 1199-1202. doi: 10.16766/j.cnki.issn.1674-4152.002557
Citation: RUI Qian-yun, CAO Shu-gang, ZHOU Xiao-ling, WANG Xiao-yuan, XUE Qun. Advances of the pathological mechanism and related factors of cognitive impairment in neuromyelitis optica spectrum disorders[J]. Chinese Journal of General Practice, 2022, 20(7): 1199-1202. doi: 10.16766/j.cnki.issn.1674-4152.002557

视神经脊髓炎谱系病认知障碍病理机制和相关因素研究进展

doi: 10.16766/j.cnki.issn.1674-4152.002557
基金项目: 

江苏省重点研发计划(社会发展)重点项目 BE2019666

详细信息
    通讯作者:

    薛群, E-mail: qxue_sz@163.com

  • 中图分类号: R744.52

Advances of the pathological mechanism and related factors of cognitive impairment in neuromyelitis optica spectrum disorders

  • 摘要: 视神经脊髓炎谱系病(neuromyelitis optica spectrum disorders,NMOSD)是一种以单侧或双侧视神经炎、横贯性脊髓炎和脑干综合征为临床特征的中枢神经系统复发性自身免疫性炎症性疾病,水通道蛋白4抗体(aquaporin-4 immunoglobulin G antibody,AQP4-IgG)是其特异性致病抗体。长期以来,大量的研究已经证明多发性硬化(multiple sclerosis,MS)患者存在认知障碍,NMOSD认知障碍的问题以往因其神经生理残疾的情况更为突出而被忽视,先前的研究考虑NMOSD脑部的病灶导致包括认知障碍在内的临床残疾,近年来随着先进的神经影像学技术的应用和认知量表的测评,系列的研究已经证明有无脑部病灶的NMOSD患者均可能存在认知障碍,这揭示了疾病进程中可能存在的脑隐匿性病理损伤,考虑到疾病本身的高复发率和高致残率,NMOSD患者隐匿发展为合并认知障碍的情况将给患者本人和家庭带来严重的经济和精神负担,NMOSD认知障碍的问题逐渐引起临床和科研工作者的重视并取得进展,包括认知障碍神经影像学预测指标、病理学改变表现、血液分子指标等。本文回顾了NMOSD认知障碍的主要相关研究,系统阐述了NMOSD认知障碍的研究现状、病理学机制、认知量表、神经影像学进展以及其他因素对其认知的影响,为临床医生在日常工作中对评估NMOSD患者认知改变、疾病进展及治疗预后提供评估依据。

     

  • 表  1  NMOSD认知障碍相关的主要研究

    Table  1.   Major studies related to cognitive impairment in NMOSD

    参考文献 量表选择 认知障碍
    BLANC F等(2008)[7] BCcogSEP(法译版BRN-B) 记忆,信息处理速度
    CTT, Go-No-Go, WAIS-R 词语流畅性,执行能力
    BDI
    HE D等(2011)[8] CVLT-Ⅱ, DST-backward 学习能力
    CLOX, SDMT 记忆,信息处理速度
    PASAT 3 s 词语流畅性,执行能力
    BDI 执行能力
    VANOTTI S等(2013)[11] MMSE 注意力,词语流畅性
    BRB-N
    LIU Y O等(2015)[23] MACFIMS, WCST 词语流畅性,记忆
    信息处理速度,执行能力
    ZHANG N等(2015)[25] MMSE, MoCA 记忆,信息处理速度,执行能力
    MACFIMS, WCST
    BDI
    KIM S H等(2016)[13] SVLT, HVLT-R, RCFT 记忆,注意力
    COWAT, SDMT, PASAT 信息处理速度
    DST, STROOP
    FUJIMORI J等(2017)[22] WAIS-Ⅲ,WMS-R 记忆,信息处理速度
    WANG J等(2017)[18] mPASAT 注意力,记忆
    LIU Y O等(2018)[4] MMSE 广泛认知
    PASAT 信息处理速度
    CHO E B等(2018)[32] DST, TMT, PASAT 注意力,工作记忆
    DSCT, SST, K-BNT 信息处理速度,执行能力
    RCFT, K-CVLT, COWAT 视空间能力
    BDI-Ⅱ, STAI
    GUO X等(2019)[21] MMSE, MoCA, 广泛认知,记忆
    CVLT-Ⅱ, BVMT-R, SDMT 视空间能力,信息处理速度
    SAVOLDI F等(2019)[6] BRB-N 注意力,执行功能
    STROOP 记忆
    CHOU I J等(2019)[33] PASAT 3 s 运动功能,信息处理速度
    FSS, T 25-FW, 9-HPT
    HAN Y L等(2019)[5] MMSE, MoCA 广泛认知
    注:CTT,color trails test,色词测验;Go-No-Go,the go/no-go test,通过/不通过测试;WAIS-R,Wechsler memory scale-revised,韦克斯勒成人智力量表;BDI,the Beck depression inventory,贝克抑郁量表;CVLT-Ⅱ,California verbal learning test-Ⅱ,加利福尼亚词语学习测试-Ⅱ;DST-backward,the backward digit span test,后向数字跨度测试;CLOX,the executive clock drawing task,钟表绘制执行测验;SDMT,symbol digit modalities test,符号数字转换测验;PASAT 3 s,the Paced Auditory Serial Addition Test interstimulus time,3.0 s,进步式听觉累加测试,刺激时间3.0 s;WCST,Wisconsin card sorting test,威斯康星卡片分类测验;SVLT,Shiraz verbal learning test,Shiraz语言学习测验;RCFT,Rey complex figure test,Rey复杂图形测试;COWAT,controlled oral word association test,口语流畅性测验;STROOP,Stroop color-word test,Stroop色词测验(SCWT);WMS-R,Wechsler memory scale-revised,韦克斯勒记忆量表修订版;mPASAT,modified PASAT,修改后的PASAT;TMT,trail making test,连线测验;DSCT,digit symbol coding test,数字符号编码测验;SST,spatial span test,空间跨度测试;K-BNT,Korean-Boston naming test,韩国版波士顿命名测试;STAI,state-trait anxiety inventory,状态特质焦虑量表;BVMT-R,the brief visuospatial memory test-revised,简短的视觉空间记忆测试修订;FSS,fatigue severity scale,疲劳强度量表;9-HPT,9-hole peg test,9孔钉测试;T 25-FW,timed 25-foot walk,定时25英尺步行。
    下载: 导出CSV
  • [1] WINGERCHUK D M, LENNON V A, LUCCHINETTI C F, et al. The spectrum of neuromyelitis optica[J]. Lancet Neurol, 2007, 6(9): 805-815. doi: 10.1016/S1474-4422(07)70216-8
    [2] 张星虎, 许贤豪. 多发性硬化及视神经脊髓炎的诊断[J]. 中华医学杂志, 2007, 87(39): 2739-2740. doi: 10.3760/j.issn:0376-2491.2007.39.002

    ZHANG X H, XU X H. Diagnosis of multiple sclerosis and neuromyelitis optica[J]. National Medical Journal of China, 2007, 87(39): 2739-2740. doi: 10.3760/j.issn:0376-2491.2007.39.002
    [3] LIU Y, XIONG H, LI X J, et al. Abnormal baseline brain activity in neuromyelitis optica patients without brain lesion detected by resting-state functional magnetic resonance imaging[J]. Neuropsychiatr Dis Treat, 2020, 16: 71-79. doi: 10.2147/NDT.S232924
    [4] LIU Y O, JIANG X Y, BUTZKUEVEN H, et al. Multimodal characterization of gray matter alterations in neuromyelitis optica[J]. Mult Scler, 2018, 24(10): 1308-1316. doi: 10.1177/1352458517721053
    [5] HAN Y L, LIU Y, ZENG C, et al. Functional Connectivity alterations in neuromyelitis optica spectrum disorder: Correlation with disease duration and cognitive impairment[J]. Clin Neuroradiol, 2020, 30(3): 559-568. doi: 10.1007/s00062-019-00802-3
    [6] SAVOLDI F, ROCCA M A, VALSASINA P, et al. Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder[J]. Mult Scler, 2020, 26(7): 795-805. doi: 10.1177/1352458519845109
    [7] BLANC F, ZÉPHIR H, LEBRUN C, et al. Cognitive functions in neuromyelitis optica[J]. Arch Neurol, 2008, 65(1): 84-88.
    [8] HE D, WU Q Z, CHEN X Y, et al. Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse[J]. Brain Cogn, 2011, 77(1): 80-88. doi: 10.1016/j.bandc.2011.05.007
    [9] MENG H, XU J, PAN C L, et al. Cognitive dysfunction in adult patients with neuromyelitis optica: A systematic review and meta-analysis[J]. J Neurol, 2017, 264(8): 1549-1558. doi: 10.1007/s00415-016-8345-3
    [10] SAJI E, ARAKAWA M, YANAGAWA K, et al. Cognitive impairment and cortical degeneration in neuromyelitis optica[J]. Ann Neurol, 2013, 73(1): 65-76. doi: 10.1002/ana.23721
    [11] VANOTTI S, CORES E V, EIZAGUIRRE B, et al. Cognitive performance of neuromyelitis optica patients: Comparison with multiple sclerosis[J]. Arq Neuropsiquiatr, 2013, 71(6): 357-361. doi: 10.1590/0004-282X20130038
    [12] HYUN J W, PARK G, KWAK K, et al. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis[J]. Eur J Neurol, 2017, 24(2): 437-445. doi: 10.1111/ene.13224
    [13] KIM S H, KWAK K, JEONG I H, et al. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis[J]. Mult Scler, 2016, 22(14): 1850-1858. doi: 10.1177/1352458516636246
    [14] POPESCU B F, PARISI J E, CABRERA-GóMEZ J A, et al. Absence of cortical demyelination in neuromyelitis optica[J]. Neurology, 2010, 75(23): 2103-2109. doi: 10.1212/WNL.0b013e318200d80c
    [15] WANG Q, ZHANG N, QIN W, et al. Gray matter volume reduction is associated with cognitive impairment in neuromyelitis optica[J]. AJNR Am J Neuroradiol, 2015, 36(10): 1822-1829. doi: 10.3174/ajnr.A4403
    [16] SALAMA S, MAROUF H, REDA M I, et al. Cognitive functions in Egyptian neuromyelitis optica spectrum disorder[J]. Clin Neurol Neurosurg, 2020, 189: 105-107.
    [17] KANEKO K, SATO D K, NAKASHIMA I, et al. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies[J]. J Neurol Neurosurg Psychiatry, 2016, 87(11): 1257-1259. doi: 10.1136/jnnp-2015-312676
    [18] WANG J, TIAN Y, SHAO Y, et al. Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: A resting-state functional MRI study[J]. Neuropsychiatr Dis Treat, 2017, 13: 2669-2679. doi: 10.2147/NDT.S145183
    [19] REZAEIMANESH N, SAEEDI R, SAHRAIAN M A, et al. The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder[J]. Mult Scler Relat Disord, 2020, 42: 102132. DOI: 10.1016/j.msard.2020.102132.
    [20] FOOLAD F, KHODAGHOLI F, NABAVI S M, et al. Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities[J]. PLoS One, 2020, 15(3): e0230691. DOI: 10.1371/journal.pone.0230691.
    [21] GUO X, ZHU J J, ZHANG N N N, et al. Altered neurovascular coupling in neuromyelitis optica[J]. Hum Brain Mapp, 2019, 40(3): 976-986. doi: 10.1002/hbm.24426
    [22] FUJIMORI J, NAKASHIMA I, BABA T, et al. Cognitive impairment in neuromyelitis optica spectrum disorders: A comparison of the Wechsler Adult Intelligence Scale-Ⅲ and the Wechsler Memory Scale Revised with the Rao Brief Repeatable Neuropsychological Battery[J]. eNeurologicalSci, 2017, 9: 3-7. doi: 10.1016/j.ensci.2017.09.001
    [23] LIU Y O, FU Y, SCHOONHEIM M M, et al. Structural MRI substrates of cognitive impairment in neuromyelitis optica[J]. Neurology, 2015, 85(17): 1491-1499. doi: 10.1212/WNL.0000000000002067
    [24] MOORE P, METHLEY A, POLLARD C, et al. Cognitive and psychiatric comorbidities in neuromyelitis optica[J]. J Neurol Sci, 2016, 360: 4-9. doi: 10.1016/j.jns.2015.11.031
    [25] ZHANG N, LI Y J, FU Y, et al. Cognitive impairment in Chinese neuromyelitis optica[J]. Mult Scler, 2015, 21(14): 1839-1846. doi: 10.1177/1352458515576982
    [26] BLANC F, NOBLET V, JUNG B, et al. White matter atrophy and cognitive dysfunctions in neuromyelitis optica[J]. PLoS One, 2012, 7(4): e33878. DOI: 10.1371/journal.pone.0033878.
    [27] DUAN Y, LIU Y, LIANG P, et al. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study[J]. Eur J Radiol, 2012, 81(2): e110-e114. doi: 10.1016/j.ejrad.2011.01.065
    [28] LIU Y O, XIE T, HE Y, et al. Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica[J]. Eur Radiol, 2014, 24(9): 2334-2343. doi: 10.1007/s00330-014-3239-1
    [29] KIM S H, KWAK K, HYUN J W, et al. Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder[J]. Eur J Neurol, 2016, 23(7): 1165-1173. doi: 10.1111/ene.13011
    [30] KIM S H, PARK E Y, PARK B, et al. Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder[J]. Sci Rep, 2017, 7(1): 9180. doi: 10.1038/s41598-017-08889-9
    [31] WANG F, LIU Y O, LI J J, et al. Abnormal brain function in neuromyelitis optica: A fMRI investigation of mPASAT[J]. Eur J Radiol, 2017, 95: 197-201. doi: 10.1016/j.ejrad.2017.08.012
    [32] CHO E B, HAN C E, SEO S W, et al. White matter network disruption and cognitive dysfunction in neuromyelitis optica spectrum disorder[J]. Front Neurol, 2018, 9: 1104-1109. doi: 10.3389/fneur.2018.01104
    [33] CHOU I J, TANASESCU R, MOUGIN O E, et al. Reduced myelin signal in normal-appearing white matter in neuromyelitis optica measured by 7t magnetic resonance imaging[J]. Sci Rep, 2019, 9(1): 143-148. doi: 10.1038/s41598-018-36505-x
    [34] KAWAHARA Y, IKEDA M, DEGUCHI K, et al. Cognitive and affective assessments of multiple sclerosis (MS) and neuromyelitis optica (NMO) patients utilizing computerized touch panel-type screening tests[J]. Intern Med, 2014, 53(20): 2281-2290. doi: 10.2169/internalmedicine.53.2571
    [35] BONNET M C, DELOIRE M S, SALORT E, et al. Evidence of cognitive compensation associated with educational level in early relapsing-remitting multiple sclerosis[J]. J Neurol Sci, 2006, 251(1-2): 23-28. doi: 10.1016/j.jns.2006.08.002
    [36] SUMOWSKI J F, ROCCA M A, LEAVITT V M, et al. Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it[J]. Neurology, 2013, 80(24): 2186-2193. doi: 10.1212/WNL.0b013e318296e98b
  • 加载中
表(1)
计量
  • 文章访问数:  213
  • HTML全文浏览量:  137
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-24
  • 网络出版日期:  2022-09-23

目录

    /

    返回文章
    返回